Paul R Edick Xeris Biopharma Holdings, Inc. (XERS) insider trading activity

Paul R Edick is Director of Xeris Biopharma Holdings, Inc.. Currently has a direct ownership of 3.79 Million shares of XERS, which is worth approximately $12.2 Million. The most recent transaction as insider was on Jan 31, 2024, when has been sold 1,500,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.79M

0% 3M change

65.56% 12M change

Total Value Held $12.2 Million

Paul R Edick Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 31 2024	BUY Grant, award, or other acquisition	-	1,500,000 Added 28.37%	3,788,064 Common Stock
Aug 09 2023	BUY Open market or private purchase	$23,800 $2.38 p/Share	10,000 Added 0.44%	2,288,064 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	-	750,000 Added 24.77%	2,278,064 Common Stock
Dec 13 2022	BUY Open market or private purchase	$29,000 $1.45 p/Share	20,000 Added 1.29%	1,528,064 Common Stock
May 12 2022	BUY Open market or private purchase	$140,000 $1.4 p/Share	100,000 Added 6.22%	1,508,064 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	600,000 Added 29.88%	1,408,064 Common Stock
Nov 11 2021	BUY Open market or private purchase	$416,000 $2.08 p/Share	200,000 Added 19.84%	808,064 Common Stock
Oct 05 2021	BUY Grant, award, or other acquisition	-	608,064 Added 50.0%	608,064 Common Stock

Also insider at

XERS

XERIS PHARMACEUTICALS INC Healthcare

Chief Executive Officer

PRE

Paul R Edick

Director

Chicago, IL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XERS shares.

Notify only if

Value

Insider Trading

Get notified when an Xeris Biopharma Holdings, Inc. insider buys or sells XERS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Xeris Biopharma Holdings, Inc.

Track Activities on XERS

Account